Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Clinical trial NCT03650114 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03650114
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-28
- Primary completion
- 2028-09-30
- Enrollment
- 1882
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.